Chronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies

Similar documents
SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

transplant Professional Education

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Your Kidneys: Master Chemists of the Body

ACCREDITATION APPLICATION FOR COUNCIL ON RENAL NUTRITION ACTIVITIES

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world

Strategic Plan Awareness Prevention Treatment

Staying Fit With Kidney Disease

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

CKD and CVD. Jamal Salameh, MD, FACP, FASN First Coast Nephrology

THE ADVANCED CHRONIC KIDNEY DISEASE MANAGEMENT TOOLKIT

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Niagara Health Quality Coalition Employers Leading The Way In Health Care Quality

QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George

DIABETES AND CHRONIC KIDNEY DISEASE

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

Introduction. 1. Introduction

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Chronic Kidney Disease: Optimal and Coordinated Management

(210) , DSN

The CARI Guidelines Caring for Australians with Renal Impairment. 5. Classification of chronic kidney disease based on evaluation of kidney function

Morbidity & Mortality from Chronic Kidney Disease

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Evidence-based practice in nephrology : Meta-analysis

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

ARE YOU AT INCREASED RISK FOR CHRONIC KIDNEY DISEASE?

Efficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia. Ioannis Griveas, MD, PhD

THE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

Future Direction of Anemia Management in ESRD. Jay B. Wish, MD 2008 Nephrology Update March 20, 2008

The National Kidney Foundation (NKF) is pleased to submit testimony regarding the impact of

Evaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Chronic Kidney Disease

NEPHROLOGISTS face a critical challenge

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

2013 Community Benefit Report

MANAGERIAL. Potential Application of the National Kidney Foundation s Chronic Kidney Disease Guidelines in a Managed Care Setting

WHAT YOU CAN DO TO MAKE A DIFFERENCE

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Case Studies: Renal and Urologic Impairments Workshop

Update on HIV-Related Kidney Diseases. Agenda

Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Managing Progressive Kidney Disease Andrew S. Narva, MD

Screening for Chronic Kidney Disease: Time to Say No

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease

APPENDIX 1: METHODS USED FOR GUIDELINE DEVELOPMENT

The vexing problem of suboptimal initiation of dialysis: Can we do better?

National Kidney Disease Education Program

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Kidneys and Kidney Disease

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

TABLE OF CONTENTS T-1. A-1 Acronyms and Abbreviations. S-1 Stages of Chronic Kidney Disease (CKD)

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

ASDIN 8th Annual Scientific Meeting

8 th Annual Congress of the Bangladesh Society of Medicine Dhaka, Bangladesh March 23-24, Jeffrey P. Harris MD, FACP

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS

MY INFORMATION: RESOURCES

STATEMENT OF THE NATIONAL KIDNEY FOUNDATION SUBMITTED TO THE HOUSE COMMITTEE ON APPROPRIATIONS;

Jai R adhakrishnan, Radhakrishnan, MD Columbia University

Therapeutic golas in the treatment of CKD-MBD

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Diabetic Kidney Disease in the Primary Care Clinic

Primary Care Approach to Management of CKD

REFERENCE CODE GDHCER052 PUBLICAT ION DATE NOVEMBER 2013 DIABETIC NEPHROPATHY - EPIDEMIOLOGY FORECAST TO 2022

KDIGO Controversies Conference on Blood Pressure in CKD

Chapter 1: CKD in the General Population

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management

HIV AND CHRONIC KIDNEY DISEASE. Understanding GFR

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

STRATEGIC PLAN 2014 to 2017

Tolvaptan for treating autosomal dominant polycystic kidney disease

AWARENESS AND EDUCATION NEEDS FOR GOUT AND CKD: SURVEY OF OPINIONS AND PRACTICES OF HEALTH CARE PROFESSIONALS

2012 Community Benefit RepoRt

Effective Health Care Program

Cardiovascular Pharmacotherapy in Special Population: Cardio-Nephrology

A n aly tical m e t h o d s

Kerry Cooper M.D. Arizona Kidney Disease and Hypertension Center April 30, 2009

Overview. Diabetes epidemiology Key elements of the VA/DoD Diabetes practice guideline How to integrate the guideline into primary care

Session 9: Optimizing the Management of Patients with Chronic Kidney Disease Learning Objectives

ASDIN 7th Annual Scientific Meeting

Dissemination and Implementation Research in Diabetes and Obesity. Christine Hunter National Institute of Diabetes and Digestive and Kidney Diseases

PHILADELPHIA KIDNEY WALK Partnership Opportunities

Pharmacological Management of Complications of End Stage Renal Disease in Patients on Maintenance Hemodialysis.

Transcription:

Chronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies Guidelines International Network November 2, 2004

The National Kidney Foundation The Mission of the National Kidney Foundation is to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and families affected by these diseases, and increase the availability of all organs for transplantation

Who Are We? Started in 1950 as a childhood nephrosis support group Concentrated on ESRD after 1964 Transplant for Public Relations Dialysis for Patient Service and Professional Education Retained that focus through the 70s, 80s and most of the 90s

Controversies in the Quality of Dialysis Care NKF sponsored Controversies in the Quality of Dialysis Care in 1993 Recommended Guidelines

Purpose: Scope: NKF s K/DOQI To improve patient outcomes through the development of clinical practice guidelines To develop guidelines that address co-morbidities and complications across the continuum of CKD Process: Guidelines are formulated with scientific rigor and undergo a structured review of content and methodology

K/DOQI Clinical Practice Guidelines 1997 VA, PD, HD, Anemia 2000 VA, PD, HD, Updates Nutrition 2002 Chronic Kidney Disease (CKD) 2003 Bone Metabolism Managing Dyslipidemias 2004 2005 J F M A M J J A S O N D J F M A M 2004 Hypertension & Antihypertensive Agents in CKD J J A S O N D HYPERTENSION IN CKD Public Review AJKD Suppl. CVD IN DIALYSIS Advisory Board Document Revisions Public Review AJKD Suppl. HD - PD - VA UPDATES Lit Search / Data Abstraction WG Meeting Advisory Board Public Review AJKD Suppl. DIABETES IN CKD ANEMIA IN CKD Lit Search Mock Guidelines WG 2 nd Meeting WG 1 st Meeting Data Abstraction Lit Search and Data Abstraction WG 3rd Meeting WG 2 nd Meeting Advisory Board Synthesis WG 4th Meeting Advisory Board WG 3rd Meeting Public Review Public Review Anticipated Publication Feb. 2006 AJKD Suppl.

K/DOQI Guideline Process Development Selection of Articles Data Analysis Evidence Report Abstraction Form Formulation of Guidelines Draft Report Three Stage Peer Review American Journal of Kidney Diseases Full Text on Searchable CD-Rom Publication of Guideline Caddy Wall Charts and Fact Sheets Audio and Video Conference Publication Implementation www.kidney.org Symposia PowerPoint Speaker Guide Patient and Family Brochures and other Tools CME Programs Guideline Update

Changes in Treatment and Outcomes K/DOQI guidelines are being widely adopted K/DOQI dialysis guidelines are the basis for clinical performances measures in the U.S. Increase in delivered dose of dialysis Increase in hemoglobin/hematocrit levels in CKD

Stages of Chronic Kidney Disease Stage Description GFR (ml/min/1.73 m 2 ) 1 Kidney Damage with Normal or GFR > 90 2 Kidney Damage with Mild GFR 60-89* 3 Moderate GFR 30-59 4 Severe GFR 15-29 5 Kidney Failure <15 or Dialysis GFR = Glomerular Filtration Rate *may be normal for age

Changes in Treatment and Outcomes K/DOQI CKD Guidelines (2002): Causing a change in the kidney community s focus: Toward CKD On what to do, not whether to do something Terminology and definitions are accepted Staging of CKD is understood NKF s numbers are being debated Topics under discussion are identified as NKF topics: Proteinuria measurement GFR reporting Early identification and treatment In-roads are being made in the primary care arena

K/DOQI Implementation

Screening, awareness Effective intervention Nationwide affiliate-based detection Finds CKD Clinical practice guidelines Improved outcomes Evaluation, classification, stratification of CKD Defines CKD Awareness and education Changes in treatment and outcomes

NKF s KEEP An evaluation program for individuals at increased risk for kidney disease Implemented through NKF Affiliates in the U.S. KEEP target audience Persons with known high blood pressure and diabetes Persons who have first degree relatives with high blood pressure, diabetes or chronic kidney disease

KEEP Trends Approximately 90% with one or more results outside normal range More than 60% learned of at least one new condition for which they showed above normal risk 85% of people screened report that they have a doctor 85% of those people had seen their doctor in the past year

Atlas of KEEP data published as an annual supplement to the American Journal of Kidney Diseases (AJKD) Second publication: March 2005 issue CD-Rom version at ASN: October 2004 KEEP Annual Data Report National Kidney Foundation

NKF s KLS Addresses patient and professional education along the continuum of chronic kidney disease (CKD) care Structured according to the K/DOQI classification of CKD Integrated with all other NKF Initiatives for needs assessment

Kidney Learning System Creating an educational matrix

NKF s KLS Meets learning needs related to: Kidney awareness Patient support K/DOQI implementation Continuing professional education Clinician support

KLS Process Recruitment of content experts Program Development Programs Concept K/DOQI Guidelines and Latest Science Pilot Testing and Evaluation Needs Assessment Patients, Physicians, Professionals, Organizations/Societies, Payors and the Public Delivery in variety of formats

KLS Resources Brochures Books/Primers Ancillary Tools, e.g., Wall Charts Pocket Cards Videos CD-ROMs Interactive Web Offerings Audio/Video/Internet Conferences NKF-Hosted Courses On-Site Courses Co-Sponsored Meetings & Symposia CME/CE Programs PDA Software Pocket PC Software

KLS Web Site

PDA and Pocket PC Software

Information you need from people you trust